Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lzsph
    Member
    • Jul 2012
    • 13

    #1

    Primers for qPCR validation in non-model RNA-Seq

    Hey guys,

    Once we got differentially expressed (DE) genes using RNA-Seq, we need to do qPCR validation.

    1.For a non-model plant, among the DE genes, maybe most of them are unknown. If you pick some known and unknown genes/transcripts to do qPCR validation, how do you design primers for those unknown (maybe novel) genes/transcripts? (qPCR primers span introns)
    2.Generally, how many genes should be selected as candidate genes?


    Any suggestions would be greatly appreciated.
    Thanks.

    Sincerely,
    lzsph
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    1. You could design a number of PCR primers at discrete intervals (0, 150, 300, 450bp) along the transcript, then test in pairwise combinations using genomic DNA vs cDNA as template. Any pair that produces bands of different sizes (gDNA > cDNA) spans an intron (you can confirm by Sanger sequencing the PCR products).

    2. It really depends upon the goal of your qPCR experiment. Remember to include a couple of non-differential genes as controls, though.

    Comment

    • lzsph
      Member
      • Jul 2012
      • 13

      #3
      Originally posted by HESmith View Post
      1. You could design a number of PCR primers at discrete intervals (0, 150, 300, 450bp) along the transcript, then test in pairwise combinations using genomic DNA vs cDNA as template. Any pair that produces bands of different sizes (gDNA > cDNA) spans an intron (you can confirm by Sanger sequencing the PCR products).

      2. It really depends upon the goal of your qPCR experiment. Remember to include a couple of non-differential genes as controls, though.
      Got it! Thank you HESmith.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Working...